114 related articles for article (PubMed ID: 23223782)
1. Targeted nanoparticles for enhanced X-ray radiation killing of multidrug-resistant bacteria.
Luo Y; Hossain M; Wang C; Qiao Y; An J; Ma L; Su M
Nanoscale; 2013 Jan; 5(2):687-94. PubMed ID: 23223782
[TBL] [Abstract][Full Text] [Related]
2. X-ray enabled detection and eradication of circulating tumor cells with nanoparticles.
Hossain M; Luo Y; Sun Z; Wang C; Zhang M; Fu H; Qiao Y; Su M
Biosens Bioelectron; 2012; 38(1):348-54. PubMed ID: 22776179
[TBL] [Abstract][Full Text] [Related]
3. Preventing bacterial growth on implanted device with an interfacial metallic film and penetrating X-rays.
An J; Sun A; Qiao Y; Zhang P; Su M
J Mater Sci Mater Med; 2015 Feb; 26(2):68. PubMed ID: 25631261
[TBL] [Abstract][Full Text] [Related]
4. First proof of bismuth oxide nanoparticles as efficient radiosensitisers on highly radioresistant cancer cells.
Stewart C; Konstantinov K; McKinnon S; Guatelli S; Lerch M; Rosenfeld A; Tehei M; Corde S
Phys Med; 2016 Nov; 32(11):1444-1452. PubMed ID: 28327297
[TBL] [Abstract][Full Text] [Related]
5. Tumor targeted, stealthy and degradable bismuth nanoparticles for enhanced X-ray radiation therapy of breast cancer.
Deng J; Xu S; Hu W; Xun X; Zheng L; Su M
Biomaterials; 2018 Feb; 154():24-33. PubMed ID: 29120816
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo simulations for dose enhancement in cancer treatment using bismuth oxide nanoparticles implanted in brain soft tissue.
Taha E; Djouider F; Banoqitah E
Australas Phys Eng Sci Med; 2018 Jun; 41(2):363-370. PubMed ID: 29582243
[TBL] [Abstract][Full Text] [Related]
7. In vitro efficacy of colistin against multi-drug resistant Pseudomonas aeruginosa by minimum inhibitory concentration.
Gill MM; Rao JU; Kaleem F; Hassan A; Khalid A; Anjum R
Pak J Pharm Sci; 2013 Jan; 26(1):7-10. PubMed ID: 23261721
[TBL] [Abstract][Full Text] [Related]
8. Accelerating the multifunctionalization of therapeutic nanoparticles by using a multicomponent reaction.
Zhou H; Su G; Jiao P; Yan B
Chemistry; 2012 Apr; 18(18):5501-5. PubMed ID: 22437991
[TBL] [Abstract][Full Text] [Related]
9. Bismuth-ethanedithiol incorporated in a liposome-loaded tobramycin formulation modulates the alginate levels in mucoid Pseudomonas aeruginosa.
Alipour M; Dorval C; Suntres ZE; Omri A
J Pharm Pharmacol; 2011 Aug; 63(8):999-1007. PubMed ID: 21718282
[TBL] [Abstract][Full Text] [Related]
10. Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer.
Chattopadhyay N; Cai Z; Pignol JP; Keller B; Lechtman E; Bendayan R; Reilly RM
Mol Pharm; 2010 Dec; 7(6):2194-206. PubMed ID: 20973534
[TBL] [Abstract][Full Text] [Related]
11. oprM as a new target for reversion of multidrug resistance in Pseudomonas aeruginosa by antisense phosphorothioate oligodeoxynucleotides.
Wang H; Meng J; Jia M; Ma X; He G; Yu J; Wang R; Bai H; Hou Z; Luo X
FEMS Immunol Med Microbiol; 2010 Dec; 60(3):275-82. PubMed ID: 20955466
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomes.
Alipour M; Suntres ZE; Lafrenie RM; Omri A
J Antimicrob Chemother; 2010 Apr; 65(4):684-93. PubMed ID: 20159770
[TBL] [Abstract][Full Text] [Related]
13. [In vitro antimicrobial activity of defensins from rabbit neutrophils against Pseudomonas aeruginosa and its multiple-drug-resistance strains].
Zhao WY; Dong BR; Zhou Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):83-5. PubMed ID: 15702789
[TBL] [Abstract][Full Text] [Related]
14. Toluidine blue O photodynamic inactivation on multidrug-resistant Pseudomonas aeruginosa.
Tseng SP; Teng LJ; Chen CT; Lo TH; Hung WC; Chen HJ; Hsueh PR; Tsai JC
Lasers Surg Med; 2009 Jul; 41(5):391-7. PubMed ID: 19533759
[TBL] [Abstract][Full Text] [Related]
15. Real-time probing of membrane transport in living microbial cells using single nanoparticle optics and living cell imaging.
Xu XH; Brownlow WJ; Kyriacou SV; Wan Q; Viola JJ
Biochemistry; 2004 Aug; 43(32):10400-13. PubMed ID: 15301539
[TBL] [Abstract][Full Text] [Related]
16. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
Hamouche E; Sarkis DK
Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex.
Nicholson A; Perry JD; James AL; Stanforth SP; Carnell S; Wilkinson K; Anjam Khan CM; De Soyza A; Gould FK
Int J Antimicrob Agents; 2012 Jan; 39(1):27-32. PubMed ID: 21993484
[TBL] [Abstract][Full Text] [Related]
18. Studies of photokilling of bacteria using titanium dioxide nanoparticles.
Tsuang YH; Sun JS; Huang YC; Lu CH; Chang WH; Wang CC
Artif Organs; 2008 Feb; 32(2):167-74. PubMed ID: 18269355
[TBL] [Abstract][Full Text] [Related]
19. Nanocellulose templated growth of ultra-small bismuth nanoparticles for enhanced radiation therapy.
Jiao L; Li Q; Deng J; Okosi N; Xia J; Su M
Nanoscale; 2018 Apr; 10(14):6751-6757. PubMed ID: 29589846
[TBL] [Abstract][Full Text] [Related]
20. Coordination of thiosemicarbazones and bis(thiosemicarbazones) to bismuth(III) as a strategy for the design of metal-based antibacterial agents.
Lessa JA; Reis DC; Da Silva JG; Paradizzi LT; da Silva NF; Carvalho Mde F; Siqueira SA; Beraldo H
Chem Biodivers; 2012 Sep; 9(9):1955-66. PubMed ID: 22976983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
